Amy Berke, MD
Family Medicine · Ann Arbor, MINPI 1245598309
Payments from drug & device makers
Across 157 payments — averaging $15.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$409
- Lilly USA, LLC$330
- Novo Nordisk$289
- GSK$268
- Johnson & Johnson$105
- Pfizer$105
- plus $965 from 22 others
What the payments were for
- Food & beverage$2,470100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 28 | $409 |
| Lilly USA, LLC | 20 | $330 |
| Novo Nordisk | 19 | $289 |
| GSK | 18 | $268 |
| Johnson & Johnson | 7 | $105 |
| Pfizer | 6 | $105 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $98 |
| AstraZeneca(2 entities) | 6 | $97 |
| Amgen(2 entities) | 5 | $83 |
| Otsuka America Pharmaceutical, Inc. | 4 | $74 |
| Amarin Pharma, Inc. | 5 | $68 |
| Supernus Pharmaceuticals, Inc. | 4 | $59 |
| Acella Pharmaceuticals, LLC | 4 | $59 |
| Astellas Pharma US Inc | 3 | $54 |
| Exact Sciences | 3 | $50 |
| Novartis | 3 | $44 |
| Kowa Pharmaceuticals America, Inc. | 3 | $39 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $38 |
| Esperion Therapeutics, Inc. | 2 | $33 |
| Teva Pharmaceuticals USA, Inc. | 2 | $28 |
| Mayne Pharma Commercial LLC | 1 | $26 |
| Almatica Pharma LLC | 1 | $23 |
| Actelion Pharmaceuticals US, Inc. | 1 | $22 |
| Idorsia Pharmaceuticals US Inc | 1 | $20 |
| Biohaven Pharmaceuticals, Inc. | 1 | $18 |
| Merck | 1 | $12 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
| Corium, LLC | 1 | $8 |
How this compares
$2,470 in reported general payments places this provider in the 80th percentile of 3,945 family medicine providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 16 | $16,840 |
| JardianceEmpagliflozin | 18 | $16,379 |
| LinzessLinaclotide | 12 | $6,273 |
| Breo ElliptaFluticasone/Vilanterol | 11 | $5,170 |
| VyvanseLisdexamfetamine Dimesylate | 12 | $4,556 |
| Lisdexamfetamine Dimesylate | 13 | $3,477 |
| Armour ThyroidThyroid,pork | 28 | $2,816 |
| Losartan Potassium | 112 | $1,653 |
| Atorvastatin Calcium | 130 | $1,511 |
| Metoprolol Succinate | 72 | $1,226 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 38 | $1,086 |
| Levothyroxine Sodium | 103 | $1,031 |
| Omeprazole | 43 | $1,013 |
| Gabapentin | 28 | $921 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 41 | $891 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $105 | $16,84016 claims |
| AbbVieLinzess, Armour Thyroid | $409 | $9,08940 claims |
| GSKBreo Ellipta | $268 | $5,17011 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Vyvanse | $12 | $4,55612 claims |
| Acella Pharmaceuticals, LLCNp Thyroid | $59 | $79719 claims |
| Almatica Pharma LLCSertraline Hcl | $23 | $32527 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,945 family medicine providers in Michigan.
Other family medicine in Ann Arbor
- Shathabish KariyannaAnn Arbor$119K
- David SerlinAnn Arbor$27K
- Angela McGradyAnn Arbor$19K
- Derrick WilliamsonSouthfield$9.9M
- Rebecca RivardRoseville$7M
- Paul BensonBerkley$4.2M
- Michael HafranEast Lansing$2.7M
- Mitzie HewittBuckley$1.3M
- Loren ChudlerSouthfield$1.3M
- Solomon AmsterWhite Lake$981K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.